U.S. stocks were lower, with the Dow Jones index falling around 200 points on Friday.
Shares of Wave Life Sciences Ltd. (NASDAQ:WVE) rose sharply during Tuesday's session after the company announced interim data from its ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne muscular dystrophy.
Wave Life Sciences shares surged 37.9% to $7.36 on Tuesday.
Here are some other big stocks recording gains in today's session.
Now Read This:
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
